Elevation Oncology
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $58 |
Gross Profit | -4 | -10 | 48 |
EBITDA | -10,959 | -9,859 | -7,936 |
EBIT | -10,963 | -9,869 | -7,946 |
Net Income | -10,461 | -10,707 | -7,899 |
Net Change In Cash | 0 | 0 | 58 |
Free Cash Flow | -8,205 | -9,575 | -12,181 |
Cash | 59,447 | 90,630 | 49,255 |
Basic Shares | 59,018 | 47,371 | 42,416 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -39 | -27 | -18 | -15 |
EBITDA | -41,467 | -94,522 | -32,028 | -17,250 |
EBIT | -41,506 | -94,549 | -32,046 | -17,265 |
Net Income | -45,704 | -95,080 | -32,039 | -17,265 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -100,367 | |||
Free Cash Flow | -56,180 | -85,569 | -30,167 | -12,369 |
Cash | 49,255 | 45,917 | 146,284 | 79,400 |
Basic Shares | 34,077 | 23,267 | 23,205 | 23,759 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.22 |
2024-06-30 | -$0.18 |
2024-03-31 | -$0.23 |
2023-12-31 | -$0.19 |
